MPN-SAF
Showing 26 - 50 of 164
Bone Marrow Fibrosis Trial in Germany (Allogeneic stem cell transplantation, Ruxolitinib continuous therapy)
Active, not recruiting
- Bone Marrow Fibrosis
- Allogeneic stem cell transplantation
- Ruxolitinib continuous therapy
-
Aachen, Germany
- +13 more
Aug 20, 2021
Myelofibrosis Trial in Hangzhou (Jaktinib HCl tablets)
Recruiting
- Myelofibrosis
- Jaktinib hydrochloride tablets
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital of Medical School of Zhejiang Univ
Nov 29, 2021
Primary Myelofibrosis, Secondary Myelofibrosis, PMF Trial in Germany (INCB018424/CC-4047)
Active, not recruiting
- Primary Myelofibrosis
- +5 more
-
Aachen, Germany
- +16 more
Sep 28, 2021
A Prospective, Two-arm, Non-interventional Study of JAKAVI® in
Active, not recruiting
- Primary Myelofibrosis
- +2 more
- Jakavi
-
Aachen, GermanyNovartis Investigative Site
Sep 6, 2021
Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase, Primary Myelofibrosis, Secondary Myelofibrosis Trial in Houston
Completed
- Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase
- +2 more
- Laboratory Biomarker Analysis
- +2 more
-
Houston, TexasM D Anderson Cancer Center
May 27, 2022
Recurrent Chronic Myelomonocytic Leukemia, Refractory Chronic Myelomonocytic Leukemia Trial in Rochester (Biospecimen
Recruiting
- Recurrent Chronic Myelomonocytic Leukemia
- Refractory Chronic Myelomonocytic Leukemia
- Biospecimen Collection
- +3 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 4, 2023
Essential Thrombocythemia, Polycythemia Vera Trial in Boston (Ruxolitinib)
Not yet recruiting
- Essential Thrombocythemia
- Polycythemia Vera
-
Boston, Massachusetts
- +2 more
Nov 24, 2020
Polycythemia Vera Trial in Worldwide (Best Available Therapy, Ruxolitinib)
Completed
- Polycythemia Vera
- Best Available Therapy
- Ruxolitinib
-
Herston, Queensland, Australia
- +47 more
Jun 29, 2021
Primary Myelofibrosis, Prefibrotic Stage, Myelofibrosis Trial in Hong Kong (Ropeginterferon alfa-2b)
Recruiting
- Primary Myelofibrosis, Prefibrotic Stage
- Myelofibrosis
- Ropeginterferon alfa-2b
-
Hong Kong, Hong KongDepartment of Medicine, the University of Hong Kong, Queen Mary
Jul 25, 2021
Epigenetic Age on Clinic-biological Presentation and Prognosis
Not yet recruiting
- Myeloproliferative Neoplasm
- Assessment of the epigenetic age
-
Bordeaux, FranceCHU de Bordeaux, service Hématologie Biologique
Aug 28, 2023
Myelofibrosis Trial in Houston (CK0804)
Not yet recruiting
- Myelofibrosis
-
Houston, TexasThe University of Texas MD Anderson Cancer Center
Jun 28, 2022
Primary Myelofibrosis Trial (Pacritinib)
Withdrawn
- Primary Myelofibrosis
- Pacritinib
- (no location specified)
May 3, 2021
PHiladelphia-nEgative Cytogenetic mYeloproliferative Neoplasms.
Not yet recruiting
- Myeloproliferative Neoplasm
- Questionnaire
- (no location specified)
May 4, 2020
Monocytes Sub-populations in Thrombosis Associated With
Recruiting
- Myeloproliferative Neoplasm
- 1 additional tube of blood
-
Bordeaux, France
- +4 more
Nov 30, 2022
Acute Megakaryoblastic Leukemia, Myelofibrosis, Primary Myelofibrosis Trial in Miami, Chicago, Rochester (Alisertib, Laboratory
Active, not recruiting
- Acute Megakaryoblastic Leukemia
- +2 more
- Alisertib
- +2 more
-
Miami, Florida
- +2 more
May 4, 2021
Polycythemia Vera Trial in Italy (AOP2014, Phlebotomies, ASA)
Active, not recruiting
- Polycythemia Vera
- AOP2014
- +2 more
-
San Giovanni Rotondo, (FG) Puglia, Italy
- +22 more
Jan 10, 2023
Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV-MF), Post-Essential Thrombocythemia MF (Post-ET-MF) Trial in
Recruiting
- Primary Myelofibrosis (PMF)
- +2 more
- KRT-232
- Best Available Therapy (BAT)
-
Birmingham, Alabama
- +155 more
Aug 12, 2022
Polycythemia Vera In US Clinical Practices (REVEAL)
Completed
- MPN (Myeloproliferative Neoplasms)
-
Green Valley, Arizona
- +265 more
Apr 22, 2021
Myeloproliferative Tumor, Secondary Leukemia Trial (Multiomic characterization, In vitro drug screening)
Not yet recruiting
- Myeloproliferative Neoplasm
- Secondary Leukemia
- Multiomic characterization
- In vitro drug screening
- (no location specified)
Aug 28, 2023
Clonal Cytopenia of Undetermined Significance, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Los Angeles
Not yet recruiting
- Clonal Cytopenia of Undetermined Significance
- +4 more
- Biospecimen Collection
- +6 more
-
Los Angeles, California
- +1 more
Oct 4, 2023
Myeloproliferative Disorder, Myeloproliferative Syndrome, Myelofibrosis Trial in Irvine (USDA Diet, Mediterranean Diet)
Completed
- Myeloproliferative Disorder
- +4 more
- USDA Diet
- Mediterranean Diet
-
Irvine, CaliforniaUniversity of California, Irvine
Mar 23, 2020